Companies: 48,874 Total Market Cap: 132429386156445.04

Merck & Co.

NYSE: MRK

Healthcare Drug Manufacturers - General

Rank #74

Market Cap 192.85 B

Volume 5.19 M

Price 76.80

Change (%) 0.97%

Country or region

United States

Merck & Co.'s latest marketcap:

192.85 B

As of 05/19/2025, Merck & Co.'s market capitalization has reached $192.85 B. According to our data, Merck & Co. is the 74th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap	192.85 B
Revenue (ttm)	63.92 B
Net Income (ttm)	17.43 B
Shares Out	2.51 B
EPS (ttm)	6.88
Forward PE	8.53
Ex-Dividend Date	03/17/2025
Earnings Date	04/24/2025

Market Cap Chart

Data Updated: 05/19/2025

Merck & Co.'s yearly market capitalization.

Merck & Co. has seen its market value grow from $175.68 B to $192.85 B since 1998, representing a total increase of 9.77% and an annual compound growth rate (CAGR) of 0.35%.

Date	Market Cap	Change (%)
05/19/2025	$192.85 B	-21.13%
12/31/2024	$251.65 B	-8.91%
12/29/2023	$276.26 B	-1.79%
12/30/2022	$281.30 B	45.31%
12/31/2021	$193.59 B	-6.46%
12/31/2020	$206.96 B	-10.62%
12/31/2019	$231.56 B	16.54%
12/31/2018	$198.69 B	29.61%
12/29/2017	$153.30 B	-5.55%
12/30/2016	$162.31 B	10%
12/31/2015	$147.55 B	-8.86%
12/31/2014	$161.90 B	10.71%
12/31/2013	$146.24 B	17.5%
12/31/2012	$124.46 B	8.31%
12/30/2011	$114.91 B	3.49%
12/31/2010	$111.03 B	44.07%
12/31/2009	$77.07 B	19.91%
12/31/2008	$64.27 B	-49.18%
12/31/2007	$126.48 B	33.62%
12/29/2006	$94.66 B	36.08%
12/30/2005	$69.56 B	-2.41%
12/31/2004	$71.27 B	-30.66%
12/31/2003	$102.79 B	-19.14%
12/31/2002	$127.12 B	-4.96%
12/31/2001	$133.75 B	-38.06%
12/29/2000	$215.92 B	37.49%
12/31/1999	$157.05 B	-10.6%
12/31/1998	$175.68 B

Company Profile

About Merck & Co., Inc.

Merck & Co., Inc. is a global healthcare company operating in two primary segments:

Pharmaceutical
Animal Health

Pharmaceutical Segment

The company provides human health pharmaceuticals across multiple therapeutic areas, including:

Oncology
Vaccines
Hospital acute care
Cardiovascular
Virology
Neuroscience
Diabetes

Key brands include Keytruda, Gardasil, Januvia, Janumet, Lagevrio, and Belsomra.

Animal Health Segment

Merck offers comprehensive veterinary solutions through:

Livestock Products: Nuflor, Bovilis, Banamine, Safe-Guard
Companion Animal Products: Bravecto, Sentinel, Caninsulin/Vetsulin
Animal Intelligence Solutions: Allflex identification and monitoring systems

Strategic Collaborations

The company maintains partnerships with leading organizations including:

Daiichi Sankyo
AstraZeneca PLC
Eisai Co., Ltd.
Bayer AG
Moderna, Inc.

Founded: 1891
Headquarters: Rahway, New Jersey

Frequently Asked Questions

As of 05/19/2025, Merck & Co. (including the parent company, if applicable) has an estimated market capitalization of $192.85 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Merck & Co. global market capitalization ranking is approximately 74 as of 05/19/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region	United States
Founded	2000
IPO Date	n/a
Employees	75,000
CEO	Robert Davis
Sector	Healthcare
Industry	Drug Manufacturers - General
Address	126 East Lincoln Avenue Rahway, New Jersey 07065 United States
Website	https://www.merck.com